These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18451646)

  • 1. Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease.
    Gluud C; Als-Nielsen B; Damgaard M; Fischer Hansen J; Hansen S; Helø OH; Hildebrandt P; Hilden J; Jensen GB; Kastrup J; Kolmos HJ; Kjøller E; Lind I; Nielsen H; Petersen L; Jespersen CM;
    Cardiology; 2008; 111(4):280-7. PubMed ID: 18451646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.
    Winkel P; Hilden J; Hansen JF; Kastrup J; Kolmos HJ; Kjøller E; Jensen GB; Skoog M; Lindschou J; Gluud C;
    Int J Cardiol; 2015 Mar; 182():459-65. PubMed ID: 25602299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.
    Carlsson AC; Ruge T; Kjøller E; Hilden J; Kolmos HJ; Sajadieh A; Kastrup J; Jensen GB; Larsson A; Nowak C; Jakobsen JC; Winkel P; Gluud C; Ärnlöv J
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease.
    Jensen GB; Hilden J; Als-Nielsen B; Damgaard M; Hansen JF; Hansen S; Helø OH; Hildebrandt P; Kastrup J; Kolmos HJ; Kjøller E; Lind I; Nielsen H; Petersen L; Jespersen CM; Gluud C;
    J Cardiovasc Pharmacol; 2010 Feb; 55(2):123-8. PubMed ID: 19920766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial.
    Jespersen CM; Kolmos HJ; Frydendall N; Hilden J; Gluud C; Hansen JF;
    J Antimicrob Chemother; 2009 Aug; 64(2):411-5. PubMed ID: 19477891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.
    Jespersen CM; Als-Nielsen B; Damgaard M; Hansen JF; Hansen S; Helø OH; Hildebrandt P; Hilden J; Jensen GB; Kastrup J; Kolmos HJ; Kjøller E; Lind I; Nielsen H; Petersen L; Gluud C;
    BMJ; 2006 Jan; 332(7532):22-7. PubMed ID: 16339220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin in coronary heart disease: excess mortality in the long term.
    Prescrire Int; 2006 Dec; 15(86):225. PubMed ID: 17167932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
    Wuopio J; Hilden J; Bring C; Kastrup J; Sajadieh A; Jensen GB; Kjøller E; Kolmos HJ; Larsson A; Jakobsen JC; Winkel P; Gluud C; Carlsson AC; Ärnlöv J
    Atherosclerosis; 2018 Nov; 278():97-102. PubMed ID: 30261474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?
    Winkel P; Hilden J; Fischer Hansen J; Hildebrandt P; Kastrup J; Kolmos HJ; Kjøller E; Jespersen CM; Gluud C; Jensen GB;
    Cardiology; 2011; 118(1):63-7. PubMed ID: 21447948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study.
    Ruge T; Carlsson AC; Kjøller E; Hilden J; Kolmos HJ; Sajadieh A; Kastrup J; Jensen GB; Larsson A; Nowak C; Jakobsen JC; Winkel P; Gluud C; Ärnlöv J
    Atherosclerosis; 2019 May; 284():202-208. PubMed ID: 30959314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Busman TA; Norris S; Notario GF
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
    Quinn J; Ruoff GE; Ziter PS
    Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial.
    Giamarellos-Bourboulis EJ; Mylona V; Antonopoulou A; Tsangaris I; Koutelidakis I; Marioli A; Raftogiannis M; Kopterides P; Lymberopoulou K; Mouktaroudi M; Papageorgiou C; Papaziogas B; Georgopoulou AP; Tsaganos T; Papadomichelakis E; Gogos C; Ladas M; Savva A; Pelekanou A; Baziaka F; Koutoukas P; Kanni T; Spyridaki A; Maniatis N; Pelekanos N; Kotsaki A; Vaki I; Douzinas EE; Koratzanis G; Armaganidis A
    J Antimicrob Chemother; 2014 Apr; 69(4):1111-8. PubMed ID: 24292991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.
    Berende A; ter Hofstede HJ; Vos FJ; van Middendorp H; Vogelaar ML; Tromp M; van den Hoogen FH; Donders AR; Evers AW; Kullberg BJ
    N Engl J Med; 2016 Mar; 374(13):1209-20. PubMed ID: 27028911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial.
    Winkel P; Jakobsen JC; Hilden J; Lange T; Jensen GB; Kjøller E; Sajadieh A; Kastrup J; Kolmos HJ; Larsson A; Ärnlöv J; Gluud C
    Diagn Progn Res; 2017; 1():10. PubMed ID: 31093541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events in people taking macrolide antibiotics versus placebo for any indication.
    Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.